Literature DB >> 24126759

The sex bias in systemic sclerosis: on the possible mechanisms underlying the female disease preponderance.

Fabio D'Amico1, Evangelia Skarmoutsou, Maria Clorinda Mazzarino.   

Abstract

Systemic sclerosis is a multifactorial and heterogeneous disease. Genetic and environmental factors are known to interplay in the onset and progression of systemic sclerosis. Sex plays an important and determinant role in the development of such a disorder. Systemic sclerosis shows a significant female preponderance. However, the reason for this female preponderance is incompletely understood. Hormonal status, genetic and epigenetic differences, and lifestyle have been considered in order to explain female preponderance in systemic sclerosis. Sex chromosomes play a determinant role in contributing to systemic sclerosis onset and progression, as well as in its sex-biased prevalence. It is known, in fact, that X chromosome contains many sex- and immuno-related genes, thus contributing to immuno tolerance and sex hormone status. This review focuses mainly on the recent progress on epigenetic mechanisms--exclusively linked to the X chromosome--which would contribute to the development of systemic sclerosis. Furthermore, we report also some hypotheses (dealing with skewed X chromosome inactivation, X gene reactivation, acquired monosomy) that have been proposed in order to justify the female preponderance in autoimmune diseases. However, despite the intensive efforts in elucidating the mechanisms involved in the pathogenesis of systemic sclerosis, many questions remain still unanswered.

Entities:  

Mesh:

Year:  2014        PMID: 24126759     DOI: 10.1007/s12016-013-8392-9

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN: 1080-0549            Impact factor:   8.667


  135 in total

1.  A gender gap in autoimmunity.

Authors:  C C Whitacre; S C Reingold; P A O'Looney
Journal:  Science       Date:  1999-02-26       Impact factor: 47.728

2.  Identification of very early lymphoid precursors in bone marrow and their regulation by estrogen.

Authors:  K L Medina; K P Garrett; L F Thompson; M I Rossi; K J Payne; P W Kincade
Journal:  Nat Immunol       Date:  2001-08       Impact factor: 25.606

3.  Prolactin synthesis by lymphocytes from patients with systemic sclerosis.

Authors:  Joanna Czuwara-Ladykowska; Justyna Sicinska; Malgorzata Olszewska; Izabela Uhrynowska-Tyszkiewicz; Lidia Rudnicka
Journal:  Biomed Pharmacother       Date:  2006-03-31       Impact factor: 6.529

4.  Altered diurnal rhythm of prolactin in systemic sclerosis.

Authors:  C Hilty; P Brühlmann; H Sprott; R E Gay; B A Michel; S Gay; M Neidhart
Journal:  J Rheumatol       Date:  2000-09       Impact factor: 4.666

5.  Association of TIMP-1 +372 SNP with digital ulcer manifestation in female systemic sclerosis patients.

Authors:  Evangelia Skarmoutsou; Fabio D'Amico; Maurizio Marchini; Grazia Malaponte; Raffaella Scorza; Maria Clorinda Mazzarino
Journal:  Hum Immunol       Date:  2012-07-20       Impact factor: 2.850

6.  Scleroderma in South Australia: further epidemiological observations supporting a stochastic explanation.

Authors:  P J Roberts-Thomson; J G Walker; T Y-T Lu; A Esterman; P Hakendorf; M D Smith; M J Ahern
Journal:  Intern Med J       Date:  2006-08       Impact factor: 2.048

Review 7.  Forming facultative heterochromatin: silencing of an X chromosome in mammalian females.

Authors:  J C Chow; C J Brown
Journal:  Cell Mol Life Sci       Date:  2003-12       Impact factor: 9.261

8.  The association of serum matrix metalloproteinases and their tissue inhibitor levels with scleroderma disease severity.

Authors:  E Toubi; A Kessel; G Grushko; E Sabo; M Rozenbaum; I Rosner
Journal:  Clin Exp Rheumatol       Date:  2002 Mar-Apr       Impact factor: 4.473

9.  The proadhesive phenotype of systemic sclerosis skin promotes myeloid cell adhesion via ICAM-1 and VCAM-1.

Authors:  Bradley J Rabquer; Yong Hou; Francesco Del Galdo; G Kenneth Haines; Michele L Gerber; Sergio A Jimenez; James R Seibold; Alisa E Koch
Journal:  Rheumatology (Oxford)       Date:  2009-05-13       Impact factor: 7.580

10.  Regulatory T cells in the skin lesions and blood of patients with systemic sclerosis and morphoea.

Authors:  E Antiga; P Quaglino; S Bellandi; W Volpi; E Del Bianco; A Comessatti; S Osella-Abate; C De Simone; A Marzano; M G Bernengo; P Fabbri; M Caproni
Journal:  Br J Dermatol       Date:  2010-01-22       Impact factor: 9.302

View more
  8 in total

1.  The challenge of treating orphan disease.

Authors:  Carlos Dias; Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2014-12       Impact factor: 8.667

Review 2.  Serum Jo-1 Autoantibody and Isolated Arthritis in the Antisynthetase Syndrome: Review of the Literature and Report of the Experience of AENEAS Collaborative Group.

Authors:  Lorenzo Cavagna; Laura Nuño; Carlo Alberto Scirè; Marcello Govoni; Francisco Javier Lopez Longo; Franco Franceschini; Rossella Neri; Santos Castañeda; Walter Alberto Sifuentes Giraldo; Roberto Caporali; Florenzo Iannone; Enrico Fusaro; Giuseppe Paolazzi; Raffaele Pellerito; Andreas Schwarting; Lesley Ann Saketkoo; Norberto Ortego-Centeno; Luca Quartuccio; Elena Bartoloni; Christof Specker; Trinitario Pina Murcia; Renato La Corte; Federica Furini; Valentina Foschi; Javier Bachiller Corral; Paolo Airò; Ilaria Cavazzana; Julia Martínez-Barrio; Michelle Hinojosa; Margherita Giannini; Simone Barsotti; Julia Menke; Kostantinos Triantafyllias; Rosetta Vitetta; Alessandra Russo; Laura Bogliolo; Gianluigi Bajocchi; Elena Bravi; Giovanni Barausse; Roberto Bortolotti; Carlo Selmi; Simone Parisi; Fausto Salaffi; Carlomaurizio Montecucco; Miguel Angel González-Gay
Journal:  Clin Rev Allergy Immunol       Date:  2017-02       Impact factor: 8.667

3.  Hyaluronic acid prevents immunosuppressive drug-induced ovarian damage via up-regulating PGRMC1 expression.

Authors:  Guangfeng Zhao; Guijun Yan; Jie Cheng; Xue Zhou; Ting Fang; Haixiang Sun; Yayi Hou; Yali Hu
Journal:  Sci Rep       Date:  2015-01-06       Impact factor: 4.379

4.  A Hypothetical Approach on Gender Differences in Cancer Diagnosis.

Authors:  Katrin Sak
Journal:  J Transl Int Med       Date:  2019-10-12

Review 5.  The contribution of epigenetics to the pathogenesis and gender dimorphism of systemic sclerosis: a comprehensive overview.

Authors:  Bianca Saveria Fioretto; Irene Rosa; Eloisa Romano; Yukai Wang; Serena Guiducci; Guohong Zhang; Mirko Manetti; Marco Matucci-Cerinic
Journal:  Ther Adv Musculoskelet Dis       Date:  2020-05-06       Impact factor: 5.346

6.  47XXY and 47XXX in Scleroderma and Myositis.

Authors:  R Hal Scofield; Valerie M Lewis; Joshua Cavitt; Biji T Kurien; Shervin Assassi; Javier Martin; Olga Gorlova; Peter Gregersen; Annette Lee; Lisa G Rider; Terrance O'Hanlon; Simon Rothwell; James Lilleker; Yuta Kochi; Chikacshi Terao; Ann Igoe; Wendy Stevens; Joanne Sahhar; Janet Roddy; Maureen Rischmueller; Sue Lester; Susanna Proudman; Sixia Chen; Matthew A Brown; Maureen D Mayes; Janine A Lamb; Frederick W Miller
Journal:  ACR Open Rheumatol       Date:  2022-03-29

Review 7.  Roads Less Traveled: Sexual Dimorphism and Mast Cell Contributions to Migraine Pathology.

Authors:  Andrea I Loewendorf; Anna Matynia; Hakob Saribekyan; Noah Gross; Marie Csete; Mike Harrington
Journal:  Front Immunol       Date:  2016-04-19       Impact factor: 7.561

8.  Gender differences in systemic sclerosis: relationship to clinical features, serologic status and outcomes.

Authors:  Christine Peoples; Thomas A Medsger; Mary Lucas; Bedda L Rosario; Carol A Feghali-Bostwick
Journal:  J Scleroderma Relat Disord       Date:  2016-07-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.